Migraine Drugs Market Size, Share, Growth, Trends and Industry Analysis Report, 2018 to 2025

The global migraine drugs market size was valued at USD 1.7 billion in 2017 and is expected to exhibit a CAGR of 18.0%%%% during the forecast period. Increased uptake of novel drug classes, launch of Calcitonin gene-related peptide (CGRP)-based therapies, and high unmet needs are some of the key factors driving market growth. Migraine is a common neurological disease characterized by recurrent attacks of severe throbbing head pain. Often unilateral, the headaches can last from four hours to three days. Pain is often associated with other symptoms such as nausea, vomiting, increased sensitivity to light (photophobia), increased sensitivity to sound (phonophobia), tingling or numbness in the extremities or legs, sweating, and diarrhea. Migraines are more frequent in women, with 17.0%%%% women reporting an attack compared to 6.0%%%% men, every year.